{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:08:37Z","timestamp":1793650117282,"version":"4.5.1"},"reference-count":127,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jaad.2017.09.074","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T09:34:29Z","timestamp":1512552869000},"page":"733-740.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":153,"title":["A systematic review of the safety and efficacy of systemic corticosteroids in atopic dermatitis"],"prefix":"10.1016","volume":"78","author":[{"given":"Sherry H.","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M.","family":"Drucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lebwohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan I.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2017.09.074_bib1","first-page":"509","article-title":"The diagnosis and graded therapy of atopic dermatitis","volume":"111","author":"Werfel","year":"2014","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.jaad.2017.09.074_bib2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-2133.2009.09561.x","article-title":"Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial","volume":"162","author":"Schmitt","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/all.12339","article-title":"Systemic therapy for atopic dermatitis","volume":"69","author":"Simon","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaad.2017.09.074_bib4","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1001\/archderm.1963.01590180038008","article-title":"Oral versus intramuscular methylprednisolone. A double-blind study","volume":"1963","author":"Stroud","year":"1963","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bib5","first-page":"301","article-title":"Rebound phenomenon to systemic corticosteroid in atopic dermatitis","volume":"33","author":"Forte","year":"2005","journal-title":"Allergol Immunnopath"},{"key":"10.1016\/j.jaad.2017.09.074_bib6","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1345\/aph.1P098","article-title":"Pediatric atopic dermatitis: a review of the medical management","volume":"44","author":"Carbone","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaad.2017.09.074_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/ggi.12771","article-title":"Atopic dermatitis in older adults: a viewpoint from geriatric dermatology","volume":"16","author":"Tanei","year":"2016","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.jaad.2017.09.074_bib8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1610-0387.2008.06834.x","article-title":"Systemic therapeutic options for severe atopic dermatitis","volume":"7","author":"BuBmann","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2017.09.074_bib9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s40272-015-0150-4","article-title":"Systemic agents for severe atopic dermatitis in children","volume":"17","author":"Notaro","year":"2015","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jaad.2017.09.074_bib10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.sder.2008.04.004","article-title":"Atopic dermatitis: systemic immunosuppressive therapy","volume":"27","author":"Akhavan","year":"2008","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2017.09.074_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.iac.2014.09.008","article-title":"Atopic dermatitis in children: clinical features, pathophysiology and treatment","volume":"35","author":"Lyons","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaad.2017.09.074_bib12","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s40265-014-0219-3","article-title":"Advances in the diagnosis and therapeutic management of atopic dermatitis","volume":"74","author":"Vestergaard","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.jaad.2017.09.074_bib13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1517\/14728214.2014.953927","article-title":"What is new in atopic dermatitis\/eczema","volume":"19","author":"Pl\u00f6tz","year":"2014","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.jaad.2017.09.074_bib14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12016-010-8226-y","article-title":"Therapeutic perspectives in atopic dermatitis","volume":"41","author":"Misery","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaad.2017.09.074_bib15","doi-asserted-by":"crossref","first-page":"ITC51","DOI":"10.7326\/0003-4819-155-9-201111010-01005","article-title":"In the clinic. Atopic dermatitis (eczema)","volume":"155","author":"Bershad","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2017.09.074_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pedneo.2015.08.005","article-title":"Childhood atopic dermatitis in Taiwan","volume":"57","author":"Wang","year":"2016","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.jaad.2017.09.074_bib17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.pcl.2013.11.002","article-title":"Atopic dermatitis","volume":"61","author":"Wolter","year":"2014","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.jaad.2017.09.074_bib18","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jaci.2013.03.016","article-title":"Systemic therapies for severe atopic dermatitis in children and adults","volume":"132","author":"Flohr","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2017.09.074_bib19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1440-0960.2006.00237.x","article-title":"Recent developments in the treatment of adult atopic dermatitis","volume":"47","author":"Pua","year":"2006","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bib20","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jaad.2005.04.026","article-title":"Therapeutic options in the treatment of psoriasis and atopic dermatitis","volume":"53","author":"Gottlieb","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bib21","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.2165\/00003495-200464230-00003","article-title":"Recent advances in treatment strategies for atopic dermatitis","volume":"64","author":"Roos","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.jaad.2017.09.074_bib22","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1136\/bmj.324.7350.1376","article-title":"Childhood atopic eczema","volume":"324","author":"Barnetson","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2017.09.074_bib23","first-page":"1191","article-title":"Atopic dermatitis: a review of diagnosis and treatment","volume":"60","author":"Correale","year":"1999","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jaad.2017.09.074_bib24","first-page":"158","article-title":"An overview on atopic dermatitis in children","volume":"15","author":"Susac","year":"2007","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1016\/j.jaad.2017.09.074_bib25","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.289.6446.651","article-title":"Combined oral and nasal beclomethasone diproprionate in children with atopic eczema: a randomized controlled trial","volume":"289","author":"Heddle","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.jaad.2017.09.074_bib26","first-page":"123","article-title":"The treatment of difficult atopic dermatitis in childhood with oral beclomethasone diproprionate","volume":"1992","author":"Aylett","year":"1992","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1016\/j.jaad.2017.09.074_bib27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00003495-200969030-00005","article-title":"Systemic therapy of atopic dermatitis in children","volume":"69","author":"Ricci","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.jaad.2017.09.074_bib28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jaad.2013.02.005","article-title":"A prospective observational study evaluating hypothalamic-pituitary-adrenal axis alteration and efficacy of intramuscular triamcinolone acetonide for steroid-responsive dermatolgoic disease","volume":"69","author":"Reddy","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bib29","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1210\/jc.2015-1218","article-title":"Adrenal insufficiency in corticosteroid use: systematic review and meta-analysis","volume":"100","author":"Broersen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2017.09.074_bib30","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3928\/00904481-20090622-08","article-title":"Systemic therapies for pediatric atopic dermatitis: a review for the primary care physician","volume":"38","author":"Shaw","year":"2009","journal-title":"Pediatr Ann"},{"key":"10.1016\/j.jaad.2017.09.074_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF02850199","article-title":"Managing childhood atopic dermatitis","volume":"20","author":"Leung","year":"2003","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaad.2017.09.074_bib32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1440-0960.2008.00451_1.x","article-title":"Systemic therapy of paediatric atopic dermatitis: an update","volume":"49","author":"Borchard","year":"2008","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bib33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1468-3083.2010.03737.x","article-title":"Atopic dermatitis in older patients: particular points","volume":"25","author":"Katsarou","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.09.074_bib34","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000323309","article-title":"Systemic therapy of atopic dermatitis in children and adults","volume":"41","author":"Simon","year":"2011","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bib35","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1046\/j.1365-2230.2000.00697.x","article-title":"Systemic therapy of atopic dermatitis","volume":"25","author":"Sidbury","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bib36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1651-2227.1994.tb18102.x","article-title":"Methylprednisolone bolus: a novel therapy for severe atopic dermatitis","volume":"83","author":"Galli","year":"1994","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jaad.2017.09.074_bib37","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0091-6749(93)90208-W","article-title":"Do some patients with atopic dermatitis require long-term oral steroid therapy?","volume":"91","author":"Sonenthal","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2017.09.074_bib38","first-page":"41","article-title":"Short stature in children with atopic eczema","volume":"1989","author":"David","year":"1989","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1016\/j.jaad.2017.09.074_bib39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1939-4551-6-6","article-title":"Difficult to control atopic dermatitis","volume":"6","author":"Darsow","year":"2013","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaad.2017.09.074_bib40","first-page":"885","article-title":"Immediate and delayed hypersensitivity to corticosteroids","volume":"9","author":"Basedow","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2017.09.074_bib41","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1398-9995.2006.01153.x","article-title":"Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology\/American Academy of Allergy, Asthma and Immunology\/PRACTALL consensus report","volume":"61","author":"Akdis","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaad.2017.09.074_bib42","first-page":"251","article-title":"Eczema therapeutics in children: what do the clinical trials say?","volume":"21","author":"Leung","year":"2015","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.jaad.2017.09.074_bib43","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000358587","article-title":"Therapeutic benefits in atopic dermatitis from patients' perspective: results of the German national health care study \u2018Atopic Health\u2019","volume":"228","author":"Steinke","year":"2014","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2017.09.074_bib44","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/bjd.12505","article-title":"The European TREatment of severe Atopic eczema in children Taskforce (TREAT) survey","volume":"169","author":"Proudfoot","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bib45","doi-asserted-by":"crossref","first-page":"172","DOI":"10.7861\/clinmedicine.12-2-172","article-title":"Systemic treatment of adult atopic dermatitis","volume":"12","author":"Cookson","year":"2012","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.jaad.2017.09.074_bib46","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.det.2007.06.009","article-title":"Atopic dermatitis: an update and review of the literature","volume":"25","author":"Lipozenci\u0107","year":"2007","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2017.09.074_bib47","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1468-3083.2012.04636.x","article-title":"Guidelines for treatment of atopic eczema (atopic dermatitis) Part II","volume":"26","author":"Ring","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.09.074_bib48","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/GRF.0000000000000089","article-title":"Dermatologic therapy in pregnancy","volume":"58","author":"Tyler","year":"2015","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jaad.2017.09.074_bib49","first-page":"59","article-title":"Atopic dermatitis. A clinical challenge","volume":"15","author":"Turner","year":"2006","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"10.1016\/j.jaad.2017.09.074_bib50","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1525-1470.1989.tb00820.x","article-title":"Advances in nondietary management of children with atopic dermatitis","volume":"6","author":"Rasmussen","year":"1989","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bib51","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1398-9995.1989.tb02465.x","article-title":"Management of atopic dermatitis","volume":"44","author":"Rasmussen","year":"1989","journal-title":"Allergy"},{"key":"10.1016\/j.jaad.2017.09.074_bib52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3810\/pgm.1997.03.183","article-title":"Atopic dermatitis. Current concepts support old therapies and spur new ones","volume":"101","author":"Landow","year":"1997","journal-title":"Postgrad Med"},{"key":"10.1016\/j.jaad.2017.09.074_bib53","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/0011-393X(95)85143-7","article-title":"A randomized, double-blind, placebo-controlled, crossover trial of systemic flunisolide in the treatment of children with severe atopic dermatitis","volume":"56","author":"La Rosa","year":"1995","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.jaad.2017.09.074_bib54","first-page":"922","article-title":"Atopic dermatitis","volume":"39","author":"Sarkar","year":"2002","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.jaad.2017.09.074_bib55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/09546638909086691","article-title":"A review of some aspects of the treatment of severe generalized eczematous dermatoses in children","volume":"1","author":"Verbov","year":"1989","journal-title":"J\u00a0Dermatologal Treat"},{"key":"10.1016\/j.jaad.2017.09.074_bib56","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/1346-8138.12065","article-title":"Consensus guidelines for the management of atopic dermatitis: an Asia-Pacific perspective","volume":"40","author":"Rubel","year":"2013","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bib57","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaad.2014.03.030","article-title":"Guidelines of care for\u00a0the management of atopic dermatitis: section 3. Management and treatment wth phototherapy and systemic agents","volume":"71","author":"Sidbury","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bib58","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1346-8138.2009.00706.x","article-title":"Guidelines for management of atopic dermatitis","volume":"36","author":"Saeki","year":"2009","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2017.09.074_bib59","first-page":"CD008426","article-title":"House dust mite reduction and avoidance measures for treating eczema","author":"Nankervis","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2017.09.074_bib60","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2340\/00015555-0207","article-title":"Systemic treatment of severe atopic eczema: a systematic review","volume":"87","author":"Schmitt","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2017.09.074_bib61","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1440-0960.1999.00357.x","article-title":"The caseload, assessment and treatment of atopic dermatitis: a survey of Australian dermatologists","volume":"40","author":"Stephens","year":"1999","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bib62","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0733-8635(18)30055-X","article-title":"Minimizing complications from systemic glucocorticosteroid use","volume":"13","author":"Nesbitt","year":"1995","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2017.09.074_bib63","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jaci.2013.07.049","article-title":"Efficacy and safety of systemic treatments of moderate-to-severe atopic dermatitis: a systematic review","volume":"133","author":"Roekevisch","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2017.09.074_bib64","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.det.2010.03.001","article-title":"Innovative management of severe hand dermatitis","volume":"28","author":"Abramovits","year":"2010","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2017.09.074_bibS1","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/bjd.12505","article-title":"The European TREatment of severe Atopic eczema in children Taskforce (TREAT) survey","volume":"169","author":"Proudfoot","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bibS2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0091-6749(93)90208-W","article-title":"Do some patients with atopic dermatitis require long-term oral steroid therapy?","volume":"91","author":"Sonenthal","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2017.09.074_bibS3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000358587","article-title":"Therapeutic benefits in atopic dermatitis from patients' perspective: results of the German national health care study \u2018Atopic Health\u2019","volume":"228","author":"Steinke","year":"2014","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2017.09.074_bibS4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.289.6446.651","article-title":"Combined oral and nasal beclomethasone diproprionate in children with atopic eczema: a randomized controlled trial","volume":"289","author":"Heddle","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.jaad.2017.09.074_bibS5","first-page":"123","article-title":"The treatment of difficult atopic dermatitis in childhood with oral beclomethasone diproprionate","volume":"1992","author":"Aylett","year":"1992","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1016\/j.jaad.2017.09.074_bibS6","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/0011-393X(95)85143-7","article-title":"A randomized, double-blind, placebo-controlled, crossover trial of systemic flunisolide in the treatment of children with severe atopic dermatitis","volume":"56","author":"La Rosa","year":"1995","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.jaad.2017.09.074_bibS7","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-2133.2009.09561.x","article-title":"Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial","volume":"162","author":"Schmitt","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bibS8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1440-0960.1999.00357.x","article-title":"The caseload, assessment and treatment of atopic dermatitis: a survey of Australian dermatologists","volume":"40","author":"Stephens","year":"1999","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bibS9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1651-2227.1994.tb18102.x","article-title":"Methylprednisolone bolus: a novel therapy for severe atopic dermatitis","volume":"83","author":"Galli","year":"1994","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jaad.2017.09.074_bibS10","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1001\/archderm.1963.01590180038008","article-title":"Oral versus intramuscular methylprednisolone. A double-blind study","volume":"1963","author":"Stroud","year":"1963","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bibS11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jaad.2013.02.005","article-title":"A prospective observational study evaluating hypothalamic-pituitary-adrenal axis alteration and efficacy of intramuscular triamcinolone acetonide for steroid-responsive dermatolgoic disease","volume":"69","author":"Reddy","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bibS12","first-page":"301","article-title":"Rebound phenomenon to systemic corticosteroid in atopic dermatitis","volume":"33","author":"Forte","year":"2005","journal-title":"Allergol Immunnopath"},{"key":"10.1016\/j.jaad.2017.09.074_bibS13","first-page":"509","article-title":"The diagnosis and graded therapy of atopic dermatitis","volume":"111","author":"Werfel","year":"2014","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.jaad.2017.09.074_bibS14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/1346-8138.12065","article-title":"Consensus guidelines for the management of atopic dermatitis: an Asia-Pacific perspective","volume":"40","author":"Rubel","year":"2013","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bibS15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/ggi.12771","article-title":"Atopic dermatitis in older adults: a viewpoint from geriatric dermatology","volume":"16","author":"Tanei","year":"2016","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.jaad.2017.09.074_bibS16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaad.2014.03.030","article-title":"Guidelines of care for\u00a0the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents","volume":"71","author":"Sidbury","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bibS17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1440-0960.2008.00451_1.x","article-title":"Systemic therapy of paediatric atopic dermatitis: an update","volume":"49","author":"Borchard","year":"2008","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bibS18","first-page":"CD008426","article-title":"House dust mite reduction and avoidance measures for treating eczema","volume":"1","author":"Nankervis","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2017.09.074_bibS19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2340\/00015555-0207","article-title":"Systemic treatment of severe atopic eczema: a systematic review","volume":"87","author":"Schmitt","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2017.09.074_bibS20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00003495-200969030-00005","article-title":"Systemic therapy of atopic dermatitis in children","volume":"69","author":"Ricci","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.jaad.2017.09.074_bibS21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/all.12339","article-title":"Systemic therapy for atopic dermatitis","volume":"69","author":"Simon","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaad.2017.09.074_bibS22","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1210\/jc.2015-1218","article-title":"Adrenal insufficiency in corticosteroid use: systematic review and meta-analysis","volume":"100","author":"Broersen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2017.09.074_bibS23","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1345\/aph.1P098","article-title":"Pediatric atopic dermatitis: a review of the medical management","volume":"44","author":"Carbone","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaad.2017.09.074_bibS24","first-page":"885","article-title":"Immediate and delayed hypersensitivity to corticosteroids","volume":"9","author":"Basedow","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2017.09.074_bibS25","first-page":"41","article-title":"Short stature in children with atopic eczema","volume":"1989","author":"David","year":"1989","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1016\/j.jaad.2017.09.074_bibS26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1610-0387.2008.06834.x","article-title":"Systemic therapeutic options for severe atopic dermatitis","volume":"7","author":"BuBmann","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2017.09.074_bibS27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s40272-015-0150-4","article-title":"Systemic agents for severe atopic dermatitis in children","volume":"17","author":"Notaro","year":"2015","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jaad.2017.09.074_bibS28","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0733-8635(18)30055-X","article-title":"Minimizing complications from systemic glucocorticosteroid use","volume":"13","author":"Nesbitt","year":"1995","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2017.09.074_bibS29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.iac.2014.09.008","article-title":"Atopic dermatitis in children: clinical features, pathophysiology and treatment","volume":"35","author":"Lyons","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaad.2017.09.074_bibS30","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3928\/00904481-20090622-08","article-title":"Systemic therapies for pediatric atopic dermatitis: a review for the primary care physician","volume":"38","author":"Shaw","year":"2009","journal-title":"Pediatr Ann"},{"key":"10.1016\/j.jaad.2017.09.074_bibS31","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s40265-014-0219-3","article-title":"Advances in the diagnosis and therapeutic management of atopic dermatitis","volume":"74","author":"Vestergaard","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.jaad.2017.09.074_bibS32","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1517\/14728214.2014.953927","article-title":"What is new in atopic dermatitis\/eczema","volume":"19","author":"Pl\u00f6tz","year":"2014","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.jaad.2017.09.074_bibS33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.7861\/clinmedicine.12-2-172","article-title":"Systemic treatment of adult atopic dermatitis","volume":"12","author":"Cookson","year":"2012","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.jaad.2017.09.074_bibS34","doi-asserted-by":"crossref","first-page":"ITC51","DOI":"10.7326\/0003-4819-155-9-201111010-01005","article-title":"In the clinic. Atopic dermatitis (eczema)","volume":"155","author":"Bershad","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2017.09.074_bibS35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1468-3083.2010.03737.x","article-title":"Atopic dermatitis in older patients: particular points","volume":"25","author":"Katsarou","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.09.074_bibS36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.det.2007.06.009","article-title":"Atopic dermatitis: an update and review of the literature","volume":"25","author":"Lipozenci\u0107","year":"2007","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2017.09.074_bibS37","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1468-3083.2012.04636.x","article-title":"Guidelines for treatment of atopic eczema (atopic dermatitis) Part II","volume":"26","author":"Ring","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.09.074_bibS38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/GRF.0000000000000089","article-title":"Dermatologic therapy in pregnancy","volume":"58","author":"Tyler","year":"2015","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jaad.2017.09.074_bibS39","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1398-9995.2006.01153.x","article-title":"Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology\/American Academy of Allergy, Asthma and Immunology\/PRACTALL Consensus Report","volume":"61","author":"Akdis","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaad.2017.09.074_bibS40","first-page":"59","article-title":"Atopic dermatitis. A clinical challenge","volume":"15","author":"Turner","year":"2006","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"10.1016\/j.jaad.2017.09.074_bibS41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1440-0960.2006.00237.x","article-title":"Recent developments in the treatment of adult atopic dermatitis","volume":"47","author":"Pua","year":"2006","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bibS42","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1046\/j.1365-2230.2000.00697.x","article-title":"Systemic therapy of atopic dermatitis","volume":"25","author":"Sidbury","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bibS43","first-page":"1191","article-title":"Atopic dermatitis: a review of diagnosis and treatment","volume":"60","author":"Correale","year":"1999","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jaad.2017.09.074_bibS44","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1525-1470.1989.tb00820.x","article-title":"Advances in nondietary management of children with atopic dermatitis","volume":"6","author":"Rasmussen","year":"1989","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bibS45","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1398-9995.1989.tb02465.x","article-title":"Management of atopic dermatitis","volume":"44","author":"Rasmussen","year":"1989","journal-title":"Allergy"},{"key":"10.1016\/j.jaad.2017.09.074_bibS46","first-page":"158","article-title":"An overview on atopic dermatitis in children","volume":"15","author":"Susac","year":"2007","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1016\/j.jaad.2017.09.074_bibS47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3810\/pgm.1997.03.183","article-title":"Atopic dermatitis. Current concepts support old therapies and spur new ones","volume":"101","author":"Landow","year":"1997","journal-title":"Postgrad Med"},{"key":"10.1016\/j.jaad.2017.09.074_bibS48","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000323309","article-title":"Systemic therapy of atopic dermatitis in children and adults","volume":"41","author":"Simon","year":"2011","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bibS49","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.2165\/00003495-200464230-00003","article-title":"Recent advances in treatment strategies for atopic dermatitis","volume":"64","author":"Roos","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.jaad.2017.09.074_bibS50","first-page":"922","article-title":"Atopic dermatitis","volume":"39","author":"Sarkar","year":"2002","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.jaad.2017.09.074_bibS51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/09546638909086691","article-title":"A review of some aspects of the treatment of severe generalized eczematous dermatoses in children","volume":"1","author":"Verbov","year":"1989","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2017.09.074_bibS52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.sder.2008.04.004","article-title":"Atopic dermatitis: systemic immunosuppressive therapy","volume":"27","author":"Akhavan","year":"2008","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2017.09.074_bibS53","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1346-8138.2009.00706.x","article-title":"Guidelines for management of atopic dermatitis","volume":"36","author":"Saeki","year":"2009","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bibS54","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pedneo.2015.08.005","article-title":"Childhood atopic dermatitis in Taiwan","volume":"57","author":"Wang","year":"2016","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.jaad.2017.09.074_bibS55","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1939-4551-6-6","article-title":"Difficult to control atopic dermatitis","volume":"6","author":"Darsow","year":"2013","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaad.2017.09.074_bibS56","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jaad.2005.04.026","article-title":"Therapeutic options in the treatment of psoriasis\u00a0and atopic dermatitis","volume":"53","author":"Gottlieb","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.09.074_bibS57","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF02850199","article-title":"Managing childhood atopic dermatitis","volume":"20","author":"Leung","year":"2003","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaad.2017.09.074_bibS58","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.pcl.2013.11.002","article-title":"Atopic dermatitis","volume":"61","author":"Wolter","year":"2014","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.jaad.2017.09.074_bibS59","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1136\/bmj.324.7350.1376","article-title":"Childhood atopic eczema","volume":"324","author":"Barnetson","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2017.09.074_bibS60","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12016-010-8226-y","article-title":"Therapeutic perspectives in atopic dermatitis","volume":"41","author":"Misery","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaad.2017.09.074_bibS61","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jaci.2013.07.049","article-title":"Efficacy and safety of systemic treatments of moderate-to-severe atopic dermatitis: a systematic review","volume":"133","author":"Roekevisch","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2017.09.074_bibS62","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.det.2010.03.001","article-title":"Innovative management of severe hand dermatitis","volume":"28","author":"Abramovits","year":"2010","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2017.09.074_bibS63","first-page":"251","article-title":"Eczema therapeutics in children: what do the clinical trials say?","volume":"21","author":"Leung","year":"2015","journal-title":"Hong Kong Med J"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217325331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217325331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:46:29Z","timestamp":1759272389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962217325331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":127,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0190962217325331"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2017.09.074","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of the safety and efficacy of systemic corticosteroids in atopic dermatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2017.09.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}